What is the treatment for Polypoidal Choroidal Vasculopathy like?
Treatments for Polypoidal Choroidal Vasculopathy have some similarity to another condition: Wet Age-Related Macular Degeneration (Wet AMD). In both conditions, a substance known as Vascular Endothelial Growth Factor (VEGF) causes leakage of blood and fluid from the abnormal blood vessels that occur both in Wet Form Age-Related Macular Degeneration and PCV. In order to stem the hemorrhage from the affected blood vessels, intraviteal injections of anti-VEGF drugs are required, depending on the patient and severity, these injections can happen as often as once every 4-6 weeks. The intended result is to control the leakage of blood and/or fluid leaked.
Photodynamic Therapy (PDT) is also used in the treatment of Polypoidal Choroidal Vasculopathy. In Photodynamic Therapy (PDT) of treatment for Polypoidal Choroidal Vasculopathy, a special type of drug is administered to the patient with PCV via injection. This drug makes the eye more sensitive to light. A specific cold laser is then used to destroy the abnormal blood vessels in the eye.
A third treatment option is used only if there are no better options available — a surgical virectomy. This surgery procedure removes the vitreous gel in the eye, and during this process, may also be used to surgically remove the fluids and blood leaked into the eye due to Polypoidal Choroidal Vasculopathy.
Despite the fact that treatment methods share similarity to that of Wet Age-Related Macular Degeneration, we recognise all patients with PCV are different and must be studied carefully for the best outcome to preserve visual acuity and optical coherence. Contact us to find out more on the individualised treatment plan that we are able to offer here at Asia Retina.